240 related articles for article (PubMed ID: 22842698)
1. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
Viale PH; Grande C; Moore S
Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
[TBL] [Abstract][Full Text] [Related]
2. Knowledge and practice among Hong Kong oncology nurses in the management of chemotherapy-induced nausea and vomiting.
So WK; Chan DN; Chan HY; Krishnasamy M; Chan T; Ling WM; Lo JC; Aranda S
Eur J Oncol Nurs; 2013 Jun; 17(3):370-4. PubMed ID: 23153452
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
4. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
Viale PH
Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
Schwartzberg LS; Grunberg SM; Kris MG
Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
[TBL] [Abstract][Full Text] [Related]
6. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting.
Tipton JM; McDaniel RW; Barbour L; Johnston MP; Kayne M; LeRoy P; Ripple ML
Clin J Oncol Nurs; 2007 Feb; 11(1):69-78. PubMed ID: 17441398
[TBL] [Abstract][Full Text] [Related]
7. Optimizing treatment outcomes in patients at risk for chemotherapy-induced nausea and vomiting.
Thompson N
Clin J Oncol Nurs; 2012 Jun; 16(3):309-13. PubMed ID: 22641323
[TBL] [Abstract][Full Text] [Related]
8. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy.
Tina Shih YC; Xu Y; Elting LS
Cancer; 2007 Aug; 110(3):678-85. PubMed ID: 17567835
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
Hawkins R; Grunberg S
Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
[TBL] [Abstract][Full Text] [Related]
10. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
11. The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey.
Krishnasamy M; Kwok-Wei So W; Yates P; de Calvo LE; Annab R; Wisniewski T; Aranda S
Cancer Nurs; 2014; 37(4):E27-35. PubMed ID: 24145248
[TBL] [Abstract][Full Text] [Related]
12. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
Decker GM; DeMeyer ES; Kisko DL
J Support Oncol; 2006 Jan; 4(1):35-41, 52. PubMed ID: 16444851
[TBL] [Abstract][Full Text] [Related]
13. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Navari RM
Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
[TBL] [Abstract][Full Text] [Related]
14. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study.
Ingersoll GL; Wasilewski A; Haller M; Pandya K; Bennett J; He H; Hoffmire C; Berry C
Oncol Nurs Forum; 2010 Mar; 37(2):213-21. PubMed ID: 20189927
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy induced nausea and vomiting: a European perspective.
Vidall C
Br J Nurs; 2011 May 27-Jun 9; 20(10):S22, S25-8. PubMed ID: 21647008
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM
J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
[TBL] [Abstract][Full Text] [Related]
17. Aprepitant for chemotherapy-induced nausea and vomiting.
Flemm LA
Clin J Oncol Nurs; 2004 Jun; 8(3):303-6. PubMed ID: 15208824
[TBL] [Abstract][Full Text] [Related]
18. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
Ihbe-Heffinger A; Ehlken B; Bernard R; Berger K; Peschel C; Eichler HG; Deuson R; Thödtmann J; Lordick F
Ann Oncol; 2004 Mar; 15(3):526-36. PubMed ID: 14998860
[TBL] [Abstract][Full Text] [Related]
19. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
[TBL] [Abstract][Full Text] [Related]
20. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
Oo TH; Hesketh PJ
Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
